Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early Primary Breast Cancer”

62 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 62 results

Not applicableApproved For MarketingNCT04100694
What this trial is testing

Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor

Who this might be right for
NRG1 FusionPancreatic CancerNon Small Cell Lung Cancer+8 more
Merus B.V.
Not applicableStudy completedNCT00002520
What this trial is testing

Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+7 more
Eastern Cooperative Oncology Group 434
Testing effectiveness (Phase 2)Active Not RecruitingNCT03157128
What this trial is testing

Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)

Who this might be right for
Non-Small Cell Lung CancerMedullary Thyroid CancerColon Cancer+1 more
Eli Lilly and Company 857
Not applicableStudy completedNCT01242800
What this trial is testing

Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer

Who this might be right for
Breast CancerStage IV Breast Cancer
Eastern Cooperative Oncology Group 390
Post-approval studies (Phase 4)Study completedNCT02816112
What this trial is testing

Granulocyte-colony Stimulating Factors or Antibiotics for Primary Prophylaxis for Febrile Neutropenia

Who this might be right for
Early Stage Breast Cancer
Ottawa Hospital Research Institute 458
Not applicableActive Not RecruitingNCT05632601
What this trial is testing

Reexamining Her Cardiovascular Risk - Ottawa WomeN's Longitudinal Cohort Study

Who this might be right for
Cardiovascular Diseases
Ottawa Heart Institute Research Corporation 176
Not applicableUnknownNCT00601406
What this trial is testing

Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer

Who this might be right for
Breast CancerCervical CancerEndometrial Cancer+7 more
The Christie NHS Foundation Trust 2,200
Not applicableActive Not RecruitingNCT05926024
What this trial is testing

Long-Term Follow-Up in Women With Early Breast Cancer Three Years of More Post Primary Treatment

Who this might be right for
Breast Cancer
UNC Lineberger Comprehensive Cancer Center 253
Not applicableActive Not RecruitingNCT05914792
What this trial is testing

Longitudinal ctDNA Surveillance for Older Women With ER+ Breast Cancer Who Omit Surgery

Who this might be right for
Breast Cancer
University of Pittsburgh 49
Very early researchWithdrawnNCT05368506
What this trial is testing

ZN-c3 for the Treatment of Metastatic Triple-Negative Breast Cancer and Advanced Ovarian Cancer

Who this might be right for
Advanced Fallopian Tube CarcinomaAdvanced Ovarian CarcinomaAdvanced Primary Peritoneal Carcinoma+8 more
OHSU Knight Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00422903
What this trial is testing

Letrozole In Combination With Lapatinib In Neoadjuvant Treatment Of Early Breast Cancer

Who this might be right for
Neoplasms, Breast
GlaxoSmithKline 92
Testing effectiveness (Phase 2)Looking for participantsNCT06150898
What this trial is testing

Ketorolac and Pregabalin Effects on breaSt Cancer (KePreSt)

Who this might be right for
Early-stage Breast CancerEstrogen-receptor-positive Breast Cancer
Jules Bordet Institute 112
Large-scale testing (Phase 3)Study completedNCT03197935
What this trial is testing

Investigate Atezolizumab and Chemotherapy Compared With Placebo and Chemotherapy in the Neoadjuvant Setting in Participants With Early Stage Triple Negative Breast Cancer

Who this might be right for
Triple-negative Breast Cancer
Hoffmann-La Roche 333
Not applicableNot Yet RecruitingNCT06834204
What this trial is testing

Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors

Who this might be right for
CancerBreast Cancer Early Stage Breast Cancer (Stage 1-3)Bladder Cancer+5 more
Rutgers, The State University of New Jersey 266
Large-scale testing (Phase 3)Study completedNCT00490139
What this trial is testing

ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D

Who this might be right for
Neoplasms, Breast
Novartis Pharmaceuticals 8,381
Early research (Phase 1)Active Not RecruitingNCT01366144
What this trial is testing

Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction

Who this might be right for
Breast CarcinomaCarcinoma of Unknown PrimaryEndometrial Carcinoma+11 more
National Cancer Institute (NCI) 94
Large-scale testing (Phase 3)Looking for participantsNCT07373782
What this trial is testing

Continuous Positive Airway Pressure (CPAP) Assisted Radiotherapy in Breast Cancer

Who this might be right for
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Universitaire Ziekenhuizen KU Leuven 53
Large-scale testing (Phase 3)Study completedNCT00553358
What this trial is testing

Neo ALTTO (Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimisation) Study

Who this might be right for
Neoplasms, Breast
Novartis Pharmaceuticals 455
Not applicableStudy completedNCT02428114
What this trial is testing

A Multi Centre Study to Determine the Feasibility of Using an Integrated Consent Model to Compare Standard of Care Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Chemotherapy-Induced Febrile Neutropenia in Early Stage Breast Cancer (React-G Study)

Who this might be right for
Early Stage Breast Cancer
Ottawa Hospital Research Institute 142
Not applicableStudy completedNCT05727813
What this trial is testing

To Detect Cryoimmunologic Response Induced by Early Breast Cancer Ultrasound-guided Cryoablation (ICE-study)

Who this might be right for
Cancer, Treatment-RelatedTumor of BreastSystemic Inflammatory Response+1 more
University of Roma La Sapienza 20
Load More Results